Cost-Effectiveness Analysis of Recombinant Zoster Vaccine at Age 50 for Chinese Adults with Mild Cognitive Impairment: A Modelling Study
Yifei Wu, Yao Yao, Jue Liu · 2026
Read Cost-Effectiveness Analysis of Recombinant Zoster Vaccine at Age 50 for Chinese Adults with Mild Cognitive Impairment: A Modelling Study by Yifei Wu, Yao Yao, Jue Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13211504.txt.
Description
Yifei Wu, Yao Yao, and Jue Liu model the value of a shingles vaccine in a 2026 study. The shot is known to cut shingles risk, and recent work hints it may also slow memory decline. The team simulated one million Chinese adults with mild memory problems, vaccinated at age fifty, over their lifetimes.
Vaccination averted about fifty-five percent of shingles cases and nearly all nerve pain cases after shingles. Dementia cases fell by about twelve percent. The cost per healthy year gained sat far below the national pay threshold. Only about six people needed shots to prevent one shingles case. Readers get an economic case for early vaccination.
Catalog record
| CREATOR | Yifei Wu, Yao Yao, Jue Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |